Rectal Radiotherapy — Intensity-modulated Radiotherapy Delivery, Delineation and Doses. Issue 2 (February 2016)

• Record Type: Journal Article
• Authors: Teoh, S.; Muirhead, R.
• Is Part Of: Clinical oncology. Volume 28:Issue 2(2016)
• Page Start: 93
• Page End: 102
• Publication Date: 2016-02
• Subjects: Dose escalation -- IMRT -- rectal cancer; Oncology -- Periodicals; Tumors -- Periodicals; Cancer -- Treatment -- Periodicals; Radiotherapy -- Periodicals; Neoplasms -- Periodicals; Cancer -- Radiotherapy; Cancer -- Treatment; Oncology; Medical radiology; Radiotherapy; Tumors; Electronic journals; Periodicals; 616.994
• DOI: 10.1016/j.clon.2015.10.012
• Languages: English
• ISSNs: 0936-6555

Abstract

Abstract: The use of intensity-modulated radiotherapy in rectal cancer is attractive in that it may reduce acute and late toxicities and potentially facilitate dose escalation. Intensity-modulated radiotherapy probably has a role in selected patients, but further investigation is required to identify the parameters for selection. Delineation of specific nodal groups allows maximal sparing of bladder and small bowel. In locally advanced tumours a simultaneous integrated boost allows dose escalation incorporating hypofractionation and a shorter overall treatment time. However, due to a sparsity of data on late toxicity in doses ≥60 Gy, doses at this level should be used with caution, ideally within prospective trials. Future studies investigating dose escalation must ascertain late toxicity as well as local control, as both can significantly affect quality of life and without both, the risk–benefit ratio cannot be calculated.